Cargando…
SGLT2-inhibitors; more than just glycosuria and diuresis
Heart failure (HF) continues to be a serious public health challenge despite significant advancements in therapeutics and is often complicated by multiple other comorbidities. Of particular concern is type 2 diabetes mellitus (T2DM) which not only amplifies the risk, but also limits the treatment op...
Autores principales: | Fathi, Amir, Vickneson, Keeran, Singh, Jagdeep S. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer US
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8024235/ https://www.ncbi.nlm.nih.gov/pubmed/33274396 http://dx.doi.org/10.1007/s10741-020-10038-w |
Ejemplares similares
-
Research into the effect Of SGLT2 inhibition on left ventricular remodelling in patients with heart failure and diabetes mellitus (REFORM) trial rationale and design
por: Singh, Jagdeep S. S., et al.
Publicado: (2016) -
Hereditary renal glycosuria, diabetes and responses to SGLT2 inhibitor
por: Ren, Qian, et al.
Publicado: (2022) -
Prolonged ketosis and glycosuria secondary to SGLT2 inhibitor therapy
por: Bobrowski, David, et al.
Publicado: (2021) -
SGLT2 Inhibitors in the Treatment of Diabetic Kidney Disease: More than Just Glucose Regulation
por: Klen, Jasna, et al.
Publicado: (2023) -
Hospital readmissions for patients with prostate cancer are higher after radiotherapy than after prostatectomy
por: Kesavan, Arshvin, et al.
Publicado: (2022)